Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

BeOne Reports 36% Response Rate for BGB-B2033 in Phase 1 Liver Cancer Trial

By Public Technologies
  • BeOne Medicines is presenting Phase 1 results at ESMO 2026 showing durable responses to BGB-B2033 in heavily pretreated liver cancer.
  • Global registrational trials of BGB-B2033 in late-line hepatocellular carcinoma are planned by the end of 2026.
  • BGB-58067 data presented October 23 showed activity against MTAP-deficient non-small cell lung cancer, including brain metastases.
  • BG-C477 showed tumor responses in previously treated lung cancer with high CEA expression; updated results will be presented October 26.
  • Both lung cancer programs are expected to advance toward late-stage development in 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeOne Medicines AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20261024371247) on October 24, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.